These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11362754)

  • 1. Merck expanded access program August 11, 1995 deadline.
    Treat Rev; 1995; (no 19):3. PubMed ID: 11362754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merck's protease inhibitor expanded access program now open.
    Smart T; Torres G
    GMHC Treat Issues; 1995; 9(7/8):10. PubMed ID: 11362649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merck protease inhibitor available to persons with CD4 count 50 or less--must register by August 11.
    AIDS Treat News; 1995 Jul; (no 227):1-2. PubMed ID: 11362618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Another option for less than 50 T4 cells.
    Treat Rev; 1995; (no 19):3. PubMed ID: 11362755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease inhibitor: Roche lottery deadline July 21.
    AIDS Treat News; 1995 Jul; (no 226):4-5. PubMed ID: 11362614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease inhibitor expanded access.
    Smart T
    GMHC Treat Issues; 1995 Jun; 9(6):3. PubMed ID: 11362689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abbott protease inhibitor lottery in January, CD4 under 50--registration now.
    AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roche and Merck begin expanded access programs for protease inhibitor drugs.
    Baker R
    BETA; 1995 Sep; ():4. PubMed ID: 11362890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment briefs.
    Gilden D
    GMHC Treat Issues; 1995 Apr; 9(4):6. PubMed ID: 11362367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Merck protease inhibitor trial seeks persons with CD4 count under 50.
    AIDS Treat News; 1995 Jun; (no 225):5. PubMed ID: 11362523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
    James JS
    AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indinavir (Crixivan), Merck protease inhibitor, approved.
    James JS
    AIDS Treat News; 1996 Mar; (no 243):1-2. PubMed ID: 11363299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitors shine in triple combinations.
    AIDS Alert; 1996 Mar; 11(3):31-2. PubMed ID: 11363243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New protease inhibitor studies.
    Treat Rev; 1995 May; (no 18):2. PubMed ID: 11362591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease inhibitor update: treatment combination strategies.
    Mascolini M
    AIDS Treat News; 1996 Jan; (no 239):3. PubMed ID: 11363085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More clinical data on protease inhibitors.
    Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):4-7. PubMed ID: 11362917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indinavir (Crixivan) access and distribution.
    James JS
    AIDS Treat News; 1996 Apr; (no 244):3-5. PubMed ID: 11363304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Getting your space on the magic crixi-van.
    Gilden D
    GMHC Treat Issues; 1996 Mar; 10(3):4. PubMed ID: 11363390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merck protease inhibitor: more news from Retroviruses Conference.
    James JS
    AIDS Treat News; 1996 Feb; (no 241):1-3. PubMed ID: 11363186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ritonavir expanded access.
    GMHC Treat Issues; 1995 Dec; 9(12):8. PubMed ID: 11363000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.